Global and United States Imatinib Mesylate Drugs Market Report & Forecast 2024-2031

Report ID: 1840823 | Published Date: Jan 2025 | No. of Page: 79 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Imatinib Mesylate Drugs Product Introduction
    1.2 Global Imatinib Mesylate Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Imatinib Mesylate Drugs Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Imatinib Mesylate Drugs Sales in Volume for the Year 2017-2028
    1.3 United States Imatinib Mesylate Drugs Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Imatinib Mesylate Drugs Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Imatinib Mesylate Drugs Sales in Volume for the Year 2017-2028
    1.4 Imatinib Mesylate Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Imatinib Mesylate Drugs in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Imatinib Mesylate Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Imatinib Mesylate Drugs Market Dynamics
        1.5.1 Imatinib Mesylate Drugs Industry Trends
        1.5.2 Imatinib Mesylate Drugs Market Drivers
        1.5.3 Imatinib Mesylate Drugs Market Challenges
        1.5.4 Imatinib Mesylate Drugs Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Imatinib Mesylate Drugs Market Segment by Type
        2.1.1 100mg
        2.1.2 400mg
    2.2 Global Imatinib Mesylate Drugs Market Size by Type
        2.2.1 Global Imatinib Mesylate Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Imatinib Mesylate Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Imatinib Mesylate Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Imatinib Mesylate Drugs Market Size by Type
        2.3.1 United States Imatinib Mesylate Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Imatinib Mesylate Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Imatinib Mesylate Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Imatinib Mesylate Drugs Market Segment by Application
        3.1.1 Hospital
        3.1.2 Pharmacy
    3.2 Global Imatinib Mesylate Drugs Market Size by Application
        3.2.1 Global Imatinib Mesylate Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Imatinib Mesylate Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Imatinib Mesylate Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Imatinib Mesylate Drugs Market Size by Application
        3.3.1 United States Imatinib Mesylate Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Imatinib Mesylate Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Imatinib Mesylate Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Imatinib Mesylate Drugs Competitor Landscape by Company
    4.1 Global Imatinib Mesylate Drugs Market Size by Company
        4.1.1 Top Global Imatinib Mesylate Drugs Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Imatinib Mesylate Drugs Revenue by Manufacturer (2017-2022)
        4.1.3 Global Imatinib Mesylate Drugs Sales by Manufacturer (2017-2022)
        4.1.4 Global Imatinib Mesylate Drugs Price by Manufacturer (2017-2022)
    4.2 Global Imatinib Mesylate Drugs Concentration Ratio (CR)
        4.2.1 Imatinib Mesylate Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Imatinib Mesylate Drugs in 2021
        4.2.3 Global Imatinib Mesylate Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Imatinib Mesylate Drugs Manufacturing Base Distribution, Product Type
        4.3.1 Global Imatinib Mesylate Drugs Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Imatinib Mesylate Drugs Product Type
        4.3.3 Date of International Manufacturers Enter into Imatinib Mesylate Drugs Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Imatinib Mesylate Drugs Market Size by Company
        4.5.1 Top Imatinib Mesylate Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Imatinib Mesylate Drugs Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Imatinib Mesylate Drugs Sales by Players (2020, 2021 & 2022)
5 Global Imatinib Mesylate Drugs Market Size by Region
    5.1 Global Imatinib Mesylate Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Imatinib Mesylate Drugs Market Size in Volume by Region (2017-2028)
        5.2.1 Global Imatinib Mesylate Drugs Sales in Volume by Region: 2017-2022
        5.2.2 Global Imatinib Mesylate Drugs Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Imatinib Mesylate Drugs Market Size in Value by Region (2017-2028)
        5.3.1 Global Imatinib Mesylate Drugs Sales in Value by Region: 2017-2022
        5.3.2 Global Imatinib Mesylate Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Imatinib Mesylate Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America Imatinib Mesylate Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Imatinib Mesylate Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Imatinib Mesylate Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Imatinib Mesylate Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe Imatinib Mesylate Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Imatinib Mesylate Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America Imatinib Mesylate Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Imatinib Mesylate Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Imatinib Mesylate Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Corporation Information
        7.1.2 Novartis Description and Business Overview
        7.1.3 Novartis Imatinib Mesylate Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Novartis Imatinib Mesylate Drugs Products Offered
        7.1.5 Novartis Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Imatinib Mesylate Drugs Industry Chain Analysis
    8.2 Imatinib Mesylate Drugs Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Imatinib Mesylate Drugs Distributors
    8.3 Imatinib Mesylate Drugs Production Mode & Process
    8.4 Imatinib Mesylate Drugs Sales and Marketing
        8.4.1 Imatinib Mesylate Drugs Sales Channels
        8.4.2 Imatinib Mesylate Drugs Distributors
    8.5 Imatinib Mesylate Drugs Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Imatinib Mesylate Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Imatinib Mesylate Drugs Market Trends
    Table 3. Imatinib Mesylate Drugs Market Drivers
    Table 4. Imatinib Mesylate Drugs Market Challenges
    Table 5. Imatinib Mesylate Drugs Market Restraints
    Table 6. Global Imatinib Mesylate Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Imatinib Mesylate Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Imatinib Mesylate Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Imatinib Mesylate Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Imatinib Mesylate Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Imatinib Mesylate Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Imatinib Mesylate Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Imatinib Mesylate Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Imatinib Mesylate Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Imatinib Mesylate Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Imatinib Mesylate Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Imatinib Mesylate Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate Drugs as of 2021)
    Table 18. Top Players of Imatinib Mesylate Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Imatinib Mesylate Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Imatinib Mesylate Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Imatinib Mesylate Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Imatinib Mesylate Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Imatinib Mesylate Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Imatinib Mesylate Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Imatinib Mesylate Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Imatinib Mesylate Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Imatinib Mesylate Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Imatinib Mesylate Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Imatinib Mesylate Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Imatinib Mesylate Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Imatinib Mesylate Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Imatinib Mesylate Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Imatinib Mesylate Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Imatinib Mesylate Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Imatinib Mesylate Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Imatinib Mesylate Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Imatinib Mesylate Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Imatinib Mesylate Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Imatinib Mesylate Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Imatinib Mesylate Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Novartis Corporation Information
    Table 43. Novartis Description and Business Overview
    Table 44. Novartis Imatinib Mesylate Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Novartis Imatinib Mesylate Drugs Product
    Table 46. Novartis Recent Development
    Table 47. Key Raw Materials Lists
    Table 48. Raw Materials Key Suppliers Lists
    Table 49. Imatinib Mesylate Drugs Customers List
    Table 50. Imatinib Mesylate Drugs Distributors List
    Table 51. Research Programs/Design for This Report
    Table 52. Key Data Information from Secondary Sources
    Table 53. Key Data Information from Primary Sources
List of Figures
    Figure 1. Imatinib Mesylate Drugs Product Picture
    Figure 2. Global Imatinib Mesylate Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Imatinib Mesylate Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Imatinib Mesylate Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Imatinib Mesylate Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Imatinib Mesylate Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Imatinib Mesylate Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Imatinib Mesylate Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Imatinib Mesylate Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Imatinib Mesylate Drugs Report Years Considered
    Figure 11. Product Picture of 100mg
    Figure 12. Product Picture of 400mg
    Figure 13. Global Imatinib Mesylate Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Imatinib Mesylate Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Imatinib Mesylate Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Imatinib Mesylate Drugs Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Imatinib Mesylate Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Imatinib Mesylate Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Imatinib Mesylate Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Imatinib Mesylate Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Imatinib Mesylate Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Imatinib Mesylate Drugs Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Imatinib Mesylate Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Imatinib Mesylate Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Hospital
    Figure 26. Product Picture of Pharmacy
    Figure 27. Global Imatinib Mesylate Drugs Market Share by Application in 2022 & 2028
    Figure 28. Global Imatinib Mesylate Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Imatinib Mesylate Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Imatinib Mesylate Drugs Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Imatinib Mesylate Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Imatinib Mesylate Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 33. United States Imatinib Mesylate Drugs Market Share by Application in 2022 & 2028
    Figure 34. United States Imatinib Mesylate Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Imatinib Mesylate Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Imatinib Mesylate Drugs Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Imatinib Mesylate Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Imatinib Mesylate Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 39. North America Imatinib Mesylate Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Imatinib Mesylate Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Imatinib Mesylate Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Imatinib Mesylate Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Imatinib Mesylate Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Imatinib Mesylate Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Imatinib Mesylate Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Imatinib Mesylate Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Imatinib Mesylate Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Imatinib Mesylate Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Imatinib Mesylate Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Imatinib Mesylate Drugs Value Chain
    Figure 73. Imatinib Mesylate Drugs Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Frequently Asked Questions
Imatinib Mesylate Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Imatinib Mesylate Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Imatinib Mesylate Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ponatinib

Ponatinib market is segmented by region (country), players, by Type and by Application. Players,  ... Read More

Ponatinib Drugs

Ponatinib Drugs market is segmented by region (country), players, by Type and by Application. Pla ... Read More

Iclusig

Iclusig market is segmented by region (country), players, by Type and by Application. Players, st ... Read More